Deep brain stimulation: State of the art and novel stimulation targets

Progress in Brain Research

Volumn 184, Issue C, 2010, Pages 311-324

  Ponce, Francisco A ^a,b   Lozano, Andres M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Deep brain stimulation; Functional neurosurgery; Parkinson's disease

Indexed keywords

LEVODOPA;

BOOK; BRADYKINESIA; BRAIN DEPTH STIMULATION; DISEASE COURSE; DRUG DOSE REDUCTION; DYSKINESIA; HUMAN; MUSCLE RIGIDITY; NEUROSURGERY; NONHUMAN; PARKINSON DISEASE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR;

EID: 77957235445     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(10)84016-6     Document Type: Chapter

References (127)

1. Abbott R.D., Petrovitch H., White L.R., Masaki K.H., Tanner C.M., Curb J.D., et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001, 57(3):456-462.
2. Agid Y., Arnulf I., Bejjani P., Bloch F., Bonnet A.M., Damier P., et al. Parkinson's disease is a neuropsychiatric disorder. Advanced Neurology 2003, 91:365-370.
3. Ahlskog J.E. Beating a dead horse: Dopamine and Parkinson disease. Neurology 2007, 69(17):1701-1711.
4. Anderson V.C., Burchiel K.J., Hogarth P., Favre J., Hammerstad J.P. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Archives of Neurology 2005, 62(4):554-560.
5. Arnulf I., Bejjani B.P., Garma L., Bonnet A.M., Houeto J.L., Damier P., et al. Improvement of sleep architecture in PD with subthalamic nucleus stimulation. Neurology 2000, 55(11):1732-1734.
6. Arnulf I., Leu S., Oudiette D. Abnormal sleep and sleepiness in Parkinson's disease. Current Opinion in Neurology 2008, 21(4):472-477.
7. Aybek S., Gronchi-Perrin A., Berney A., Chiuve S.C., Villemure J.G., Burkhard P.R., et al. Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease. Movement Disorder 2007, 22(7):974-981.
8. Benabid A.L. Targeting the caudal intralaminar nuclei for functional neurosurgery of movement disorders. Brain Research Bulletin 2009, 78(2-3):109-112.
9. Benabid A.L., Mitrofanis J., Chabardes S., Seigneuret E., Torres N., Piallat B., et al. Subthalamic nucleus stimulation for Parkinson's disease. Textbook of stereotactic and functional neurosurgery 2009, 1603-1630. Springer-Verlag, Heidelberg, Berlin. 2nd ed. A.M. Lozano, P.L. Gildenberg, R.R. Tasker (Eds.).
10. Benabid A.L., Pollak P., Gross C., Hoffmann D., Benazzouz A., Gao D.M., et al. Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotactic and Functional Neurosurgery 1994, 62(1-4):76-84.
11. Benabid A.L., Pollak P., Hommel M., Gaio J.M., de Rougemont J., Perret J. [Treatment of Parkinson tremor by chronic stimulation of the ventral intermediate nucleus of the thalamus]. Revue Neurologique (Paris) 1989, 145(4):320-323.
12. Benabid A.L., Pollak P., Louveau A., Henry S., de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Applied Neurophysiology 1987, 50(1-6):344-346.
13. Benabid A.L., Vercucil L., Benazzouz A., Koudsie A., Chabardes S., Minotti L., et al. Deep brain stimulation: what does it offer?. Advances in Neurology 2003, 91:293-302.
14. Bosboom J.L., Stoffers D., Wolters E. Cognitive dysfunction and dementia in Parkinson's disease. Journal of Neural Transmission 2004, 111(10-11):1303-1315.
15. Braak H., Braak E., Yilmazer D., de Vos R.A., Jansen E.N., Bohl J., et al. Amygdala pathology in Parkinson's disease. ACTA Neuropathologica 1994, 88(6):493-500.
16. Braak H., Braak E., Yilmazer D., Schultz C., de Vos R.A., Jansen E.N. Nigral and extranigral pathology in Parkinson's disease. Journal of Neural Transmission 1995, 46:15-31.
17. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen, Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging 2003, 24:197-211.
18. Bruet N., Windels F., Bertrand A., Feuerstein C., Poupard A., Savasta M. High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats. Journal of Neuropathology and Experimental Neurology 2001, 60(1):15-24.
19. Burchiel K.J., Anderson V.C., Favre J., Hammerstad J.P. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: Results of a randomized, blinded pilot study. Neurosurgery 1999, 45(6):1375-1382. discussion 1382-1374.
20. Charles P.D., Van Blercom N., Krack P., Lee S.L., Xie J., Besson G., et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 2002, 59(6):932-934.
21. Chomiak T., Hu B. Axonal and somatic filtering of antidromically evoked cortical excitation by simulated deep brain stimulation in rat brain. Journal of Physiology 2007, 579(Pt 2):403-412.
22. Cicolin A., Lopiano L., Zibetti M., Torre E., Tavella A., Guastamacchia G., et al. Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients. Sleep Medicine 2004, 5(2):207-210.
23. Comella C.L., Nardine T.M., Diederich N.J., Stebbins G.T. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology 1998, 51(2):526-529.
24. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. New England Journal of Medicine 2001, 345(13):956-963. Deep-Brain Stimulation for Parkinson's Disease Study Group.
25. Del Tredici K., Rub U., De Vos R.A., Bohl J.R., Braak H. Where does parkinson disease pathology begin in the brain?. Journal of Neuropathology and Experimental Neurology 2002, 61(5):413-426.
26. Derost P.P., Ouchchane L., Morand D., Ulla M., Llorca P.M., Barget M., et al. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?. Neurology 2007, 68(17):1345-1355.
27. Deuschl G., Schade-Brittinger C., Krack P., Volkmann J., Schafer H., Botzel K., et al. A randomized trial of deep-brain stimulation for Parkinson's disease. New England Journal of Medicine 2006, 355(9):896-908.
28. Diamond A., Jankovic J. The effect of deep brain stimulation on quality of life in movement disorders. Journal of Neurology Neurosurgery and Psychiatry 2005, 76(9):1188-1193.
29. Durif F., Lemaire J.J., Debilly B., Dordain G. Long-term follow-up of globus pallidus chronic stimulation in advanced Parkinson's disease. Movement Disorder 2002, 17(4):803-807.
30. Fahn S. How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?. Annals of Neurology 2008, 64(Suppl 2):S56-S64.
31. Ferraye M.U., Debu B., Fraix V., Goetz L., Ardouin C., Yelnik J., et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 2010, 133(Pt 1):205-214.
32. Finazzi-Agro E., Peppe A., D'Amico A., Petta F., Mazzone P., Stanzione P., et al. Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease. Journal of Urology 2003, 169(4):1388-1391.
33. Florio T., Scarnati E., Confalone G., Minchella D., Galati S., Stanzione P., et al. High-frequency stimulation of the subthalamic nucleus modulates the activity of pedunculopontine neurons through direct activation of excitatory fibres as well as through indirect activation of inhibitory pallidal fibres in the rat. European Journal of Neuroscience 2007, 25(4):1174-1186.
34. Fraix V., Pollak P., Van Blercom N., Xie J., Krack P., Koudsie A., et al. Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease. Neurology 2000, 55(12):1921-1923.
35. Fuentes R., Petersson P., Siesser W.B., Caron M.G., Nicolelis M.A. Spinal cord stimulation restores locomotion in animal models of Parkinson's disease. Science 2009, 323(5921):1578-1582.
36. Galati S., Mazzone P., Fedele E., Pisani A., Peppe A., Pierantozzi M., et al. Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease. European Journal of Neuroscience 2006, 23(11):2923-2928.
37. Gatev P., Darbin O., Wichmann T. Oscillations in the basal ganglia under normal conditions and in movement disorders. Movement Disorder 2006, 21(10):1566-1577.
38. Ghika J., Villemure J.G., Fankhauser H., Favre J., Assal G., Ghika-Schmid F. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: A 2-year follow-up review. Journal of Neurosurgery 1998, 89(5):713-718.
39. Gorgulho A.A., Shields D.C., Malkasian D., Behnke E., Desalles A.A. Stereotactic coordinates associated with facial musculature contraction during high-frequency stimulation of the subthalamic nucleus. Journal of Neurosurgery 2009, 110(6):1317-1321.
40. Gradinaru V., Mogri M., Thompson K.R., Henderson J.M., Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science 2009, 324(5925):354-359.
41. Haberler C., Alesch F., Mazal P.R., Pilz P., Jellinger K., Pinter M.M., et al. No tissue damage by chronic deep brain stimulation in Parkinson's disease. Annals of Neurology 2000, 48(3):372-376.
42. Hammond C., Ammari R., Bioulac B., Garcia L. Latest view on the mechanism of action of deep brain stimulation. Movement Disorder 2008, 23(15):2111-2121.
43. Hammond C., Bergman H., Brown P. Pathological synchronization in Parkinson's disease: Networks, models and treatments. Trends in Neurosciences 2007, 30(7):357-364.
44. Hammond C., Rouzaire-Dubois B., Feger J., Jackson A., Crossman A.R. Anatomical and electrophysiological studies on the reciprocal projections between the subthalamic nucleus and nucleus tegmenti pedunculopontinus in the rat. Neuroscience 1983, 9(1):41-52.
45. Hantz P., Caradoc-Davies G., Caradoc-Davies T., Weatherall M., Dixon G. Depression in Parkinson's disease. American Journal of Psychiatry 1994, 151(7):1010-1014.
46. Harding A.J., Broe G.A., Halliday G.M. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002, 125(Pt 2):391-403.
47. Harding A.J., Stimson E., Henderson J.M., Halliday G.M. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain 2002, 125(Pt 11):2431-2445.
48. Hariz M.I., Johansson F., Shamsgovara P., Johansson E., Hariz G.M., Fagerlund M. Bilateral subthalamic nucleus stimulation in a parkinsonian patient with preoperative deficits in speech and cognition: Persistent improvement in mobility but increased dependency: A case study. Movement Disorder 2000, 15(1):136-139.
49. Hariz M.I., Rehncrona S., Quinn N.P., Speelman J.D., Wensing C. Multicenter study on deep brain stimulation in Parkinson's disease: An independent assessment of reported adverse events at 4 years. Movement Disorder 2008, 23(3):416-421.
50. Hashimoto T., Elder C.M., Okun M.S., Patrick S.K., Vitek J.L. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. Journal of Neuroscience 2003, 23(5):1916-1923.
51. Herzog J., Volkmann J., Krack P., Kopper F., Potter M., Lorenz D., et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Movement Disorder 2003, 18(11):1332-1337.
52. Hilker R., Portman A.T., Voges J., Staal M.J., Burghaus L., van Laar T., et al. Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. Journal of Neurology, Neurosurgery and Psychiatry 2005, 76(9):1217-1221.
53. Hilker R., Voges J., Ghaemi M., Lehrke R., Rudolf J., Koulousakis A., et al. Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans. Movement Disorder 2003, 18(1):41-48.
54. Hirsch E.C. Biochemistry of Parkinson's disease with special reference to the dopaminergic systems. Molecular Neurobiology 1994, 9(1-3):135-142.
55. Hirsch E.C., Graybiel A.M., Duyckaerts C., Javoy-Agid F. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proceedings of the National Academy of Sciences of the United States of America 1987, 84:5976-5980.
56. Hjort N., Ostergaard K., Dupont E. Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus. Movement Disorder 2004, 19(2):196-199.
57. Houeto J.L., Mesnage V., Welter M.L., Mallet L., Agid Y., Bejjani B.P. Subthalamic DBS replaces levodopa in Parkinson's disease: Two-year follow-up. Neurology 2003, 60(1):154-155. author reply 154-155.
58. Juri C., Chana P., Tapia J., Kunstmann C., Parrao T. Quetiapine for insomnia in Parkinson disease: Results from an open-label trial. Clinical Neuropharmacology 2005, 28(4):185-187.
59. Kalaitzakis M.E., Christian L.M., Moran L.B., Graeber M.B., Pearce R.K., Gentleman S.M. Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease. Parkinsonism and Related Disorders 2009, 15(3):196-204.
60. Kerkerian-Le Goff L., Bacci J.J., Jouve L., Melon C., Salin P. Impact of surgery targeting the caudal intralaminar thalamic nuclei on the pathophysiological functioning of basal ganglia in a rat model of Parkinson's disease. Brain Research Bulletin 2009, 78(2-3):80-84.
61. Kinomura S., Larsson J., Gulyas B., Roland P.E. Activation by attention of the human reticular formation and thalamic intralaminar nuclei. Science 1996, 271(5248):512-515.
62. Kleiner-Fisman G., Fisman D.N., Sime E., Saint-Cyr J.A., Lozano A.M., Lang A.E. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. Journal of Neurosurgery 2003, 99(3):489-495.
63. Kleiner-Fisman G., Herzog J., Fisman D.N., Tamma F., Lyons K.E., Pahwa R., et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Movement Disorder 2006, 21(Suppl 14):S290-S304.
64. Krack P., Batir A., Van Blercom N., Chabardes S., Fraix V., Ardouin C., et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. New England Journal of Medicine 2003, 349(20):1925-1934.
65. Krack P., Pollak P., Limousin P., Benazzouz A., Deuschl G., Benabid A.L. From off-period dystonia to peak-dose chorea-The clinical spectrum of varying subthalamic nucleus activity. [Review]. Brain 1999, 122:1133-1146.
66. Krack P., Pollak P., Limousin P., Hoffmann D., Xie J., Benazzouz A., et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998, 121(Pt 3):451-457.
67. Krauss J.K., Pohle T., Weigel R., Burgunder J.M. Deep brain stimulation of the centre median-parafascicular complex in patients with movement disorders. Journal of Neurology, Neurosurgery and Psychiatry 2002, 72(4):546-548.
68. Kumar R., Lozano A.M., Kim Y.J., Hutchison W.D., Sime E., Halket E., et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998, 51(3):850-855.
69. Lacombe E., Carcenac C., Boulet S., Feuerstein C., Bertrand A., Poupard A., et al. High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats. European Journal of Neuroscience 2007, 26(6):1670-1680.
70. Lagrange E., Krack P., Moro E., Ardouin C., Van Blercom N., Chabardes S., et al. Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology 2002, 59(12):1976-1978.
71. Lang A.E., Houeto J.L., Krack P., Kubu C., Lyons K.E., Moro E., et al. Deep brain stimulation: Preoperative issues. Movement Disorders 2006, 21:S171-S196.
72. Lang A.E., Houeto J.L., Krack P., Kubu C., Lyons K.E., Moro E., et al. Deep brain stimulation: Preoperative issues. Movement Disorder 2006, 21(Suppl 14):S171-S196.
73. Lang A.E., Kleiner-Fisman G., Saint-Cyr J.A., Miyasaki J., Lozano A. Subthalamic DBS replaces levodopa in Parkinson's disease: Two-year follow-up. Neurology 2003, 60(1):154-155. author reply 154-155.
74. Latt M.D., Lord S.R., Morris J.G., Fung V.S. Clinical and physiological assessments for elucidating falls risk in Parkinson's disease. Movement Disorder 2009, 24(9):1280-1289.
75. Lee K.H., Chang S.Y., Roberts D.W., Kim U. Neurotransmitter release from high-frequency stimulation of the subthalamic nucleus. Journal of Neurosurgery 2004, 101(3):511-517.
76. Lezcano E., Gomez-Esteban J.C., Zarranz J.J., Lambarri I., Madoz P., Bilbao G., et al. Improvement in quality of life in patients with advanced Parkinson's disease following bilateral deep-brain stimulation in subthalamic nucleus. European Journal of Neurology 2004, 11(7):451-454.
77. Limousin P., Krack P., Pollak P., Benazzouz A., Ardouin C., Hoffmann D., et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. New England Journal of Medicine 1998, 339(16):1105-1111.
78. Limousin P., Martinez-Torres I. Deep brain stimulation for Parkinson's disease. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics 2008, 5(2):309-319.
79. Loher T.J., Burgunder J.M., Weber S., Sommerhalder R., Krauss J.K. Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 2002, 73(4):395-399.
80. Lozano A.M., Mahant N. Deep brain stimulation surgery for Parkinson's disease: Mechanisms and consequences. Parkinsonism and Related Disorders 2004, 10(Suppl 1):S49-S57.
81. Lyons K.E., Pahwa R. Long-term benefits in quality of life provided by bilateral subthalamic stimulation in patients with Parkinson disease. Journal of Neurosurgery 2005, 103(2):252-255.
82. Maltete D., Jodoin N., Karachi C., Houeto J.L., Navarro S., Cornu P., et al. Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease. Journal of Neurophysiology 2007, 97(6):4017-4022.
83. Manfredsson F.P., Tumer N., Erdos B., Landa T., Broxson C.S., Sullivan L.F., et al. Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesity. Molecular Therapy 2009, 17(6):980-991.
84. Marin C., Rodriguez-Oroz M.C., Obeso J.A. Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: Have we wasted our time?. Experimental Neurology 2006, 197(2):269-274.
85. Mazzone P., Lozano A., Stanzione P., Galati S., Scarnati E., Peppe A., et al. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport 2005, 16(17):1877-1881.
86. McIntyre C.C., Grill W.M., Sherman D.L., Thakor N.V. Cellular effects of deep brain stimulation: model-based analysis of activation and inhibition. Journal of Neurophysiology 2004, 91(4):1457-1469.
87. Meissner W., Harnack D., Reese R., Paul G., Reum T., Ansorge M., et al. High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats. Journal of Neurochemistry 2003, 85(3):601-609.
88. Mihalko W.M., Whiteside L.A., Krackow K.A. Comparison of ligament-balancing techniques during total knee arthroplasty. Journal of Bone and Joint Surgery American 2003, 85-A(Suppl 4):132-135.
89. Miyazato H., Skinner R.D., Garcia-Rill E. Neurochemical modulation of the P13 midlatency auditory evoked potential in the rat. Neuroscience 1999, 92(3):911-920.
90. Munro-Davies L.E., Winter J., Aziz T.Z., Stein J.F. The role of the pedunculopontine region in basal-ganglia mechanisms of akinesia. Experimental Brain Research 1999, 129(4):511-517.
91. Nanda B., Galvan A., Smith Y., Wichmann T. Effects of stimulation of the centromedian nucleus of the thalamus on the activity of striatal cells in awake rhesus monkeys. European Journal of Neuroscience 2009, 29(3):588-598.
92. Nandi D., Jenkinson N., Stein J., Aziz T. The pedunculopontine nucleus in Parkinson's disease: Primate studies. British Journal of Neurosurgery 2008, 22(Suppl 1):S4-S8.
93. Nandi D., Liu X., Winter J.L., Aziz T.Z., Stein J.F. Deep brain stimulation of the pedunculopontine region in the normal non-human primate. Journal of Clinical Neuroscience 2002, 9(2):170-174.
94. Ostergaard K., Aa Sunde N. Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus. Movement Disorder 2006, 21(5):624-631.
95. Ostergaard K., Sunde N., Dupont E. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations. [Article]. Movement Disorders 2002, 17(4):693-700.
96. Pahapill P.A., Lozano A.M. The pedunculopontine nucleus and Parkinson's disease. Brain 2000, 123(Pt 9):1767-1783.
97. Paulus W., Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease. Journal of Neuropathology and Experimental Neurology 1991, 50(6):743-755.
98. Pereira E.A., Muthusamy K.A., De Pennington N., Joint C.A., Aziz T.Z. Deep brain stimulation of the pedunculopontine nucleus in Parkinson's disease. Preliminary experience at Oxford. British Journal of Neurosurgery 2008, 22(Suppl 1):S41-S44.
99. Pinto S., Gentil M., Krack P., Sauleau P., Fraix V., Benabid A.L., et al. Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech. Movement Disorder 2005, 20(11):1507-1515.
100. Plaha P., Gill S.S. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease. Neuroreport 2005, 16(17):1883-1887.
101. Prescott I.A., Dostrovsky J.O., Moro E., Hodaie M., Lozano A.M., Hutchison W.D. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients. Brain 2009, 132(Pt 2):309-318.
102. Rodriguez M.C., Obeso J.A., Olanow C.W. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: A target for neuroprotection. Annals of Neurology 1998, 44(3 Suppl 1):S175-S188.
103. Rodriguez-Oroz M.C., Obeso J.A., Lang A.E., Houeto J.L., Pollak P., Rehncrona S., et al. Bilateral deep brain stimulation in Parkinson's disease: A multicentre study with 4 years follow-up. Brain 2005, 128(Pt 10):2240-2249.
104. Rodriguez-Oroz M.C., Zamarbide I., Guridi J., Palmero M.R., Obeso J.A. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation. Journal of Neurology, Neurosurgery and Psychiatry 2004, 75(10):1382-1385.
105. Schenck C.H., Bundlie S.R., Ettinger M.G., Mahowald M.W. Chronic behavioral disorders of human REM sleep: A new category of parasomnia. Sleep 1986, 9(2):293-308.
106. Schrag A., Jahanshahi M., Quinn N. What contributes to quality of life in patients with Parkinson's disease?. Journal of Neurology, Neurosurgery and Psychiatry 2000, 69(3):308-312.
107. Schupbach W.M., Chastan N., Welter M.L., Houeto J.L., Mesnage V., Bonnet A.M., et al. Stimulation of the subthalamic nucleus in Parkinson's disease: A 5 year follow up. Journal of Neurology, Neurosurgery and Psychiatry 2005, 76(12):1640-1644.
108. Seif C., Herzog J., van der Horst C., Schrader B., Volkmann J., Deuschl G., et al. Effect of subthalamic deep brain stimulation on the function of the urinary bladder. Annals of Neurology 2004, 55(1):118-120.
109. Stefani A., Lozano A.M., Peppe A., Stanzione P., Galati S., Tropepi D., et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007, 130(6):1596-1607.
110. Stefani A., Peppe A., Pierantozzi M., Galati S., Moschella V., Stanzione P., et al. Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex. Brain Research Bulletin 2009, 78(2-3):113-118.
111. Strafella A.P., Sadikot A.F., Dagher A. Subthalamic deep brain stimulation does not induce striatal dopamine release in Parkinson's disease. Neuroreport 2003, 14(9):1287-1289.
112. Temel Y., Visser-Vandewalle V., Kaplan S., Kozan R., Daemen M.A., Blokland A., et al. Protection of nigral cell death by bilateral subthalamic nucleus stimulation. Brain Research 2006, 1120(1):100-105.
113. Toda H., Hamani C., Fawcett A.P., Hutchison W.D., Lozano A.M. The regulation of adult rodent hippocampal neurogenesis by deep brain stimulation. Journal of Neurosurgery 2008, 108(1):132-138.
114. Uhlhaas P.J., Singer W. Neural synchrony in brain disorders: Relevance for cognitive dysfunctions and pathophysiology. Neuron 2006, 52(1):155-168.
115. Volkmann J., Albanese A., Kulisevsky J., Tornqvist A.-L., Houeto J.-L., Pidoux B., et al. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Movement Disorder 2009, 24(8):1154-1161.
116. Volkmann J., Sturm V., Weiss P., Kappler J., Voges J., Koulousakis A., et al. Bilateral high-frequency stimulation of the internal globus pallidus in advanced Parkinson's disease. Annals of Neurology 1998, 44(6):953-961.
117. Voon V., Kubu C., Krack P., Houeto J.L., Troster A.I. Deep brain stimulation: Neuropsychological and neuropsychiatric issues. [Review]. Movement Disorders 2006, 21:S305-S327.
118. Wakabayashi K., Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease. European Neurology 1997, 38(Suppl 2):2-7.
119. Wallace B.A., Ashkan K., Heise C.E., Foote K.D., Torres N., Mitrofanis J., et al. Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain 2007, 130(Pt 8):2129-2145.
120. Weaver F.M., Follett K., Stern M., Hur K., Harris C., Marks W.J., et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: A randomized controlled trial. JAMA: The Journal of the American Medical Association 2009, 301(1):63-73.
121. Weigel R., Krauss J.K. Center median-parafascicular complex and pain control. Review from a neurosurgical perspective. Stereotactic and Functional Neurosurgery 2004, 82(2-3):115-126.
122. Weinberger M., Hamani C., Hutchison W.D., Moro E., Lozano A.M., Dostrovsky J.O. Pedunculopontine nucleus microelectrode recordings in movement disorder patients. Experimental Brain Research 2008, 188(2):165-174.
123. Welter M.L., Houeto J.L., Tezenas du Montcel S., Mesnage V., Bonnet A.M., Pillon B., et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 2002, 125(Pt 3):575-583.
124. Whelan P.J. Control of locomotion in the decerebrate cat. Progress in Neurobiology 1996, 49(5):481-515.
125. Winge K., Nielsen K.K., Stimpel H., Lokkegaard A., Jensen S.R., Werdelin L. Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: Effects of deep brain stimulation in the subthalamic nucleus. Movement Disorder 2007, 22(2):220-225.
126. Xie J., Krack P., Benabid A.L., Pollak P. Effect of bilateral subthalamic nucleus stimulation on parkinsonian gait. Journal of Neurology 2001, 248(12):1068-1072.
127. Zibetti M., Torre E., Cinquepalmi A., Rosso M., Ducati A., Bergamasco B., et al. Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. European Neurology 2007, 58(4):218-223.